wedge
Acute Stroke Animal Models & Preclinical CRO Services
Acute Stroke Animal Models & Preclinical CRO Services BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO Acute Stroke Animal Models & Preclinical CRO Services Acute Stroke Animal Models & CRO Services - Preclinical Research - Seth P. Finklestein M.D., CEO
Acute Stroke Animal Models & Preclinical CRO Services Acute Stroke Animal Models & Preclinical CRO Services Acute Stroke Animal Models & Preclinical CRO Services Acute Stroke Animal Models & Preclinical CRO Services Acute Stroke Animal Models & Preclinical CRO Services
 
Home
greybar
The Company
greybar
Preclinical Drug Development
greybar
Preclinical Research Services
PK/PD Studies

Acute Stroke

Stroke Recovery

Intracerebral Hemorrhage

Alzheimer's Disease

Amyotrophic Lateral Sclerosis

Traumatic Brain Injury

Spinal Cord Injury

Muscular Dystrophy

Myocardial Infarction

Peripheral Vascular Disease

Others

Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us


Well-equipped CRO laboratory
 

Acute Stroke Animal Models & CRO Services

Acute Stroke Animal Models & CRO Services - Preclinical ResearchStroke is the third leading cause of death and disability in the U.S., with approximate 800,000 new cases per year. Eighty-five percent of strokes are "ischemic," due to occlusion of a brain artery, causing death of brain tissue (infarction) supplied by that artery.

Acute stroke treatments are given within a few hours after stroke onset. Such treatments include thrombolytic ("clot-busting") and tissue-sparing ("neuroprotective") agents. Biotrofix is highly experienced in rodent (mouse and rat) models of acute focal stroke, including suture-occlusion, Chen, Tamura, and embolic methods. These models are suitable for testing of new thrombolytic and neuroprotective strategies. Endpoints of these studies include histology (infarct volume determination) and behavioral testing.

Download ACUTE STROKE NEUROPROTECTION MODEL (.pdf)


Contact Biotrofic for Acute Stroke Research

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 604 Webster Street, Needham, MA 02494 Tel: 781-786-8890 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.